Cancer Research Services
-
Manufactured by Celemics, Inc.based in SOUTH KOREA
Customized Targeted Sequencing. BRCA1,2 (Breast Cancer). OncoRisk. CancerScreen / CancerMaster. G-Mendeliome Clinical Exome Sequnecing. G-Mendeliome Disease Specific. Customized RNA Sequencing. Customized Methy;ation Sequencing. ctDNA (Colorectal, Lung, ...
-
Manufactured by BioMark Diagnostics Inc.based in CANADA
Liquid Biopsy Metabolic Panels Being Developed for Other Cancers; Glioblastoma (GBM), Breast Cancer, Head & Neck ...
-
Manufactured by Creative Biogene-Mitochondrial Researchbased in USA
and products to assist researchers in cancer-related mitochondria ...
-
based in USA
Solutions, our commercial subsidiary, we form multidisciplinary teams to meet the special needs of our clients. Whether we are evaluating the economic benefits of new health coverage plans or developing new drugs to treat cancer, our researchers and scientists work to improve all aspects of human ...
-
by Genmab A/Sbased in DENMARK
Using our antibody expertise to transform how cancer is treated; As a leader in the discovery and development of antibody therapeutics, we are inspired by nature, passionate about innovation and driven by data. Our commitment to patients pushes us to use our antibody biology expertise to pursue and produce differentiated, next-generation ...
-
based in USA
Bespoke AI models created for you: Whether you are looking to accelerate your preclinical analysis or scale your pathology services, you can now enhance your image analysis workflow with Aiforia. With our Custom AI Services Aiforia scientists build AI models for your specific needs. With AI you can automate manual image analysis tasks to save time and costs, standardize analysis across your whole ...
-
based in USA
Champions Oncology is transforming drug discovery and development through our integrated scientific approach. Our expert team works to improve cancer outcomes each day for our research partners and ultimately patients across the ...
-
Manufactured by Veracytebased in FRANCE
for translational research and assesses the expression of 770 genes involved in the immune response to cancer in the tumor microenvironment. We offer additional Nanostring panels and custom panels designed to fit your specific ...
-
based in USA
It took nearly a century of research for doctors to learn what causes this cancer, who is most at risk for contracting it, what symptoms indicate its presence and what tools are most effective at diagnosing it. These strides significantly impacted how medical professionals treat asbestos cancer, but the investigation is hardly finished. ...
-
based in INDIA
ArrayGen offers a range of Next Generation Sequencing (NGS) data analysis for disease association studies, cancer genomics, personalized medicine, agriculture biotechnology and life sciences to help researchers derive meaningful conclusions from their data. We are a team of data analysis experts, bioinformatics tool developers, and life ...
-
Manufactured by Ozgene Pty Ltd.based in AUSTRALIA
. There are components of mouse biology systems that are inconsistent with their human counterparts, particularly the immune system. Humanized mouse models have begun to fill this gap and have become important pre-clinical tools for biomedical research. The use of humanized mice may facilitate the application of customised treatment in the medical ...
-
Manufactured by Grail, Inc.based in USA
Assessing the Implementation of an Investigational Multi-Cancer Early Detection Test into Clinical Practice. The PATHFINDER Study is a prospective, multi-center study that will evaluate the implementation of GRAIL’s multi-cancer early detection test into clinical practice. GRAIL’s test is designed to detect and localize multiple ...
-
based in USA
Champions Oncology's ex vivo AML co-culture platform for Immuno-Oncology therapeutic testing. Champions Oncology has launched an innovative new platform enabling Acute Myeloid Leukemia (AML) researchers the ability to better understand their therapeutic mechanism of action. The Autologous AML Platform is an ex vivo co-culture assay ...
-
based in USA
Champions Oncology's ex vivo 3D co-culture platform for Immuno-Oncology therapeutic testing. Champions Oncology has launched an innovative new platform enabling Immuno-Oncology researchers the ability to test their therapeutics in a 3D organoid assay that can mimic mechanism of action. The Autologous TIL platform is an ex vivo 3D ...
-
Manufactured by Grail, Inc.based in USA
Evaluation of a New Blood Test for Detecting Multiple Types of Cancer Early. The SUMMIT Study is a prospective, observational, longitudinal, cohort study being conducted in London in the United Kingdom. It is designed to enroll approximately 25,000 men and women age 50 to 77 years who do not have a cancer diagnosis at the time of ...
-
based in INDIA
ArrayGen offers a range of Next Generation Sequencing (NGS) data analysis for disease association studies, cancer genomics, personalized medicine, agriculture biotechnology and life sciences to help researchers derive meaningful conclusions from their data. We are a team of data analysis experts, bioinformatics tool developers, and life ...
-
Manufactured by Creative Bioarraybased in USA
Migration is a key property of live cells and critical for normal development, immune response, and disease processes such as cancer metastasis and inflammation. Methods to examine cell migration are very useful and important for a wide range of biomedical research such as cancer biology, immunology, vascular biology, cell ...
-
Manufactured by Alfa Chemistrybased in USA
Ifosfamide has been effectively employed in the treatment of multiple cancers, including testicular cancer, soft tissue sarcoma, osteosarcoma, bladder cancer, small cell lung cancer, non-Hodgkin lymphoma, Hodgkin lymphoma, epithelial ovarian cancer, cervical carcinoma and germ cell carcinoma of the ovary[1]. ...
-
by xCuresbased in USA
xCures’ patient-centric focus ensures that advanced cancer patients continuously engage with the xCures platform. Patients and their treating physicians receive decision support and access to leading therapeutics and diagnostics in return for ongoing access to their electronic medical records throughout their cancer journey. This ...
-
Manufactured by Grail, Inc.based in USA
Mapping the Landscape of Genomic Cancer Signals in the Blood. The Circulating Cell-free Genome Atlas (CCGA) Study is a prospective, observational, longitudinal, study designed to characterize the landscape of genomic cancer signals in the blood of people with and without cancer. The study has enrolled approximately 15,000 participants across ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you